Proteinea

Rewiring immune function with precision engineered antibodies

Cambridge, Egypt · Founded 2020 · $250K raised

Headquarters
Cambridge
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$250K
Last Round
$250K SeedMar 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Proteinea is a TechBio company transforming drug discovery and development by integrating advanced biotechnology with artificial intelligence. The company specializes in rational engineering of antibody Fc domains to enable context-specific immune tuning, enhanced half-life, and targeted biodistribution, combining AI-driven prediction with therapeutic insight. Proteinea's proprietary AI models and computational tools engineer next-generation antibodies with improved efficacy, safety, and manufacturability, with operations in Cambridge MA, Cairo, KAUST, and Munich.

Summary

Proteinea is a Biotech company based in Cambridge, Egypt, founded in 2020. It has raised $250K in total across 1 round, most recently a $250K Seed round in Mar 2021. Investors include IndieBio.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2021
$250K

Investors

Similar Companies

Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Proteinea on Indexed.vc
<a href="https://indexed.vc/companies/proteinea"><img src="https://indexed.vc/api/badge/company/proteinea" alt="Proteinea on Indexed.vc" width="260" height="76" /></a>